Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Convertible Debt (2023 - 2025)

Fractyl Health's Convertible Debt history spans 3 years, with the latest figure at $20.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Convertible Debt changed 0.0% year-over-year to $20.9 million, compared with a TTM value of $20.9 million through Dec 2025, changed 0.0%, and an annual FY2025 reading of $20.9 million, changed 0.0% over the prior year.
  • Convertible Debt for Q4 2025 was $20.9 million at Fractyl Health, roughly flat from $20.9 million in the prior quarter.
  • The five-year high for Convertible Debt was $27.2 million in Q4 2023, with the low at $20.9 million in Q1 2024.
  • Average Convertible Debt over 3 years is $21.6 million, with a median of $20.9 million recorded in 2025.
  • Year-over-year, Convertible Debt decreased 23.06% in 2024 and then rose 0.0% in 2025.
  • Tracing GUTS's Convertible Debt over 3 years: stood at $27.2 million in 2023, then decreased by 23.06% to $20.9 million in 2024, then grew by 0.0% to $20.9 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Convertible Debt are $20.9 million (Q4 2025), $20.9 million (Q3 2025), and $20.9 million (Q2 2025).